This information was published on 2026-05-29T12:27:40 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2653040 (IR 1917249) |
| (220) |
06 Apr 2026
|
| (300) |
US, 20 Oct 2025, 99452363
US, 20 Oct 2025, 99452366 |
| (511) (510) |
Class 5
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, respiratory, cardiovascular, oncological, hepatological, ophthalmic, neurological, genetic, and immune system-related diseases. Class 42 Research and development in the field of biotechnology; research and development for the pharmaceutical industry. |
| (540) | GENERAL CONTROL |
| (550) | Word |
| (730) |
Epi Labs Inc.
|
Find out more about publications on the About page.